Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Ambrx Biopharma, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Ambrx Biopharma, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Ambrx Biopharma, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Ambrx Biopharma, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Ambrx Biopharma Cayman, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Ambrx Biopharma Cayman, Inc.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Ambrx Biopharma Cayman, Inc.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Ambrx Biopharma Cayman, Inc.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Ambrx Biopharma Cayman, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Ambrx Biopharma Cayman, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Ambrx Biopharma Cayman, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |